Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Works of Yi Ren being referenced
Outcomes of first-line immune checkpoint inhibitors with or without chemotherapy according to KRAS mutational status and PD-L1 expression in patients with advanced NSCLC: FDA pooled analysis.
2022
IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yi Ren | 89 | 26 | 89 | 148 | 28 | 356 | |
| Matthieu Sarabi | 61 | 27 | 65 | 160 | 27 | 394 | |
| Ken Dabanaka | 126 | 47 | 87 | 110 | 30 | 410 | |
| Hayato Urushima | 120 | 12 | 50 | 103 | 16 | 367 | |
| Jietao Lin | 129 | 12 | 51 | 88 | 38 | 354 | |
| Chao Zhang | 147 | 18 | 54 | 71 | 20 | 311 | |
| Mi-Young Kim | 164 | 32 | 38 | 93 | 22 | 393 | |
| Xiufeng Zheng | 126 | 8 | 93 | 105 | 24 | 408 | |
| Wonwoo Kim | 125 | 9 | 54 | 108 | 31 | 381 | |
| Lijin Zhao | 145 | 15 | 52 | 87 | 43 | 351 | |
| Hiromichi Yamai | 105 | 8 | 125 | 120 | 34 | 404 |
All Works
Login with ORCID to disown or claim papers
Loading papers...